Teva : TEVA

All Teva Articles

450 Articles

Lee Jackson | Jun 27, 2018 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: AT&T, Abbott Labs, Honeywell, Tiffany, Zimmer Biomet and More

The top analyst upgrades, downgrades and other research calls from Wednesday include AT&T, Abbott Laboratories, Honeywell, Tiffany and Zimmer Biomet.

Chris Lange | Jun 12, 2018 at 10:49 AM EDT

Major Pharmaceuticals Scare Off Short Sellers

Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay…

Chris Lange | May 25, 2018 at 9:35 AM EDT

Major Pharma Short Sellers Grow More Selective

The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | May 24, 2018 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Broadcom, Deere, Generac, McDermott, NetApp, NRG, Petrobras, Teva, Tiffany and More

The top analyst upgrades, downgrades and other research calls from Thursday include Broadcom, Deere, Generac, McDermott, NetApp, NRG Energy, Petrobras,…

Trey Thoelcke | May 18, 2018 at 8:00 AM EDT

Amgen’s Novel Migraine Treatment Gets Key Approval

Amgen shares saw a nice bump after the FDA on Thursday approved its preventive treatment of migraine in adults.

Chris Lange | May 10, 2018 at 10:20 AM EDT

Short Sellers Run for Cover From Major Pharma

The April 30 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | May 3, 2018 at 8:35 AM EDT

Is This the Turnaround Teva Has Been Waiting For?

Teva Pharmaceutical Industries released its most recent quarterly report before the markets opened on Thursday.

Trey Thoelcke | Apr 29, 2018 at 10:20 AM EDT

Alibaba, CVS, Tesla and Other Earnings to Watch For This Week

24/7 Wall St. has put together a preview of Alibaba, CVS, Tesla and some of the other most anticipated earnings…

Chris Lange | Apr 25, 2018 at 8:35 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Apr 12, 2018 at 10:45 AM EDT

3 Contrarian Stocks to Buy for Surprising Upside

Credit Suisse's fresh contrarian picks include Cleveland-Cliffs, Ralph Lauren and Teva Pharmaceutical Industries.

Chris Lange | Apr 11, 2018 at 8:30 AM EDT

The Major Pharma Stocks That Are Making Short Sellers Sick

The March 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Mar 27, 2018 at 8:45 AM EDT

Which Major Pharma Stocks Short Sellers Are Keen On

The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Mar 12, 2018 at 8:35 AM EDT

Major Pharma Sees Big Drop in Short Interest

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Feb 28, 2018 at 9:10 AM EST

Short Sellers Hike Bets in Major Pharma

The February 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Feb 14, 2018 at 4:55 PM EST

Warren Buffett and Berkshire Hathaway Reveal Top Stocks for 2018

24/7 Wall St. has tracked many of the so-called whale watching trades made by America's top investment managers, hedge fund…

1 … 6 7 8 9 10 … 30

Teva : TEVA

All Teva Articles

Top Analyst Upgrades and Downgrades: AT&T, Abbott Labs, Honeywell, Tiffany, Zimmer Biomet and More

Major Pharmaceuticals Scare Off Short Sellers

Major Pharma Short Sellers Grow More Selective

Top Analyst Upgrades and Downgrades: Broadcom, Deere, Generac, McDermott, NetApp, NRG, Petrobras, Teva, Tiffany and More

Amgen’s Novel Migraine Treatment Gets Key Approval

Short Sellers Run for Cover From Major Pharma

Is This the Turnaround Teva Has Been Waiting For?

Alibaba, CVS, Tesla and Other Earnings to Watch For This Week

Short Sellers Grow More Selective on Major Pharma Stocks

3 Contrarian Stocks to Buy for Surprising Upside

The Major Pharma Stocks That Are Making Short Sellers Sick

Which Major Pharma Stocks Short Sellers Are Keen On

Major Pharma Sees Big Drop in Short Interest

Short Sellers Hike Bets in Major Pharma

Warren Buffett and Berkshire Hathaway Reveal Top Stocks for 2018

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Teva : TEVA

All Teva Articles

Top Analyst Upgrades and Downgrades: AT&T, Abbott Labs, Honeywell, Tiffany, Zimmer Biomet and More

Major Pharmaceuticals Scare Off Short Sellers

Major Pharma Short Sellers Grow More Selective

Top Analyst Upgrades and Downgrades: Broadcom, Deere, Generac, McDermott, NetApp, NRG, Petrobras, Teva, Tiffany and More

Amgen’s Novel Migraine Treatment Gets Key Approval

Short Sellers Run for Cover From Major Pharma

Is This the Turnaround Teva Has Been Waiting For?

Alibaba, CVS, Tesla and Other Earnings to Watch For This Week

Short Sellers Grow More Selective on Major Pharma Stocks

3 Contrarian Stocks to Buy for Surprising Upside

The Major Pharma Stocks That Are Making Short Sellers Sick

Which Major Pharma Stocks Short Sellers Are Keen On

Major Pharma Sees Big Drop in Short Interest

Short Sellers Hike Bets in Major Pharma

Warren Buffett and Berkshire Hathaway Reveal Top Stocks for 2018

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do